Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals

Neurobiology of Aging

Volumn 36, Issue 3, 2015, Pages 1519-1528

  Winder Rhodes, Sophie E ^a,b   Hampshire, Adam ^c,d   Rowe, James B ^a,c,e   Peelle, Jonathan E ^f   Robbins, Trevor W ^e   Owen, Adrian M ^c,g   Barker, Roger A ^a,e  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c MRC COGNITION AND BRAIN SCIENCES UNIT   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Aging; Cognitive impairment; Dementia; FMRI; Genetics; Hippocampus; MAPT; Memory; Parkinson's disease; Picture recognition; Tau

Indexed keywords

TAU PROTEIN; MAPT PROTEIN, HUMAN; OXYGEN;

ADULT; AGED; AGING; ARTICLE; BOLD SIGNAL; CLINICAL ARTICLE; CONNECTOME; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; FUSIFORM GYRUS; GENDER; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HAPLOTYPE; HIPPOCAMPUS; HOMOZYGOSITY; HUMAN; IMAGE ANALYSIS; INFERIOR TEMPORAL GYRUS; LEFT HEMISPHERE; MALE; MAPT GENE; MEMORY DISORDER; MIDDLE TEMPORAL GYRUS; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAHIPPOCAMPAL GYRUS; PARKINSON DISEASE; PRIORITY JOURNAL; RECOGNITION; RIGHT HEMISPHERE; TASK PERFORMANCE; BLOOD; COGNITION; DISEASE COURSE; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; MEMORY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; RISK; TEMPORAL LOBE;

AGED; AGING; COGNITION; DISEASE PROGRESSION; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MIDDLE AGED; OXYGEN; PARKINSON DISEASE; RISK; TAU PROTEINS; TEMPORAL LOBE;

EID: 84923532150     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.12.006     Document Type: Article

References (48)

1. Aarsland D., Andersen K., Larsen J.P., Lolk A., Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch. Neurol. 2003, 60:387-392.
2. Aarsland D., Bronnick K., Williams-Gray C., Weintraub D., Marder K., Kulisevsky J., Burn D., Barone P., Pagonabarraga J., Allcock L., Santangelo G., Foltynie T., Janvin C., Larsen J.P., Barker R.A., Emre M. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 2010, 75:1062-1069.
3. Aarsland D., Perry R., Brown A., Larsen J.P., Ballard C. Neuropathology of dementia in Parkinson's disease: a prospective, community-based study. Ann. Neurol. 2005, 58:773-776.
4. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:561-571.
5. Bondi M.W., Houston W.S., Eyler L.T., Brown G.G. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 2005, 64:501-508.
6. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C., Small G.W. Patterns of brain activation in people at risk for Alzheimer's disease. N.Engl. J. Med. 2000, 343:450-456.
7. Brett M, Anton J-L, Valabregue R, Poline J-B. Region of interest analysis using an SPM toolbox [abstract]. Present. 8th Int. Conf. Funct. Mapp. Hum. Brain June 2-6, 2002 Sendai Jpn. Available CD-ROM NeuroImage Vol. 16 No 22002.
8. Brewer J.B., Zhao Z., Desmond J.E., Glover G.H., Gabrieli J.D. Making memories: brain activity that predicts how well visual experience will be remembered. Science 1998, 281:1185-1187.
9. Bullmore E.T., Suckling J., Overmeyer S., Rabe-Hesketh S., Taylor E., Brammer M.J. Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain. IEEE Trans. Med. Imaging 1999, 18:32-42.
10. Caffrey T.M., Wade-Martins R. Functional MAPT haplotypes: bridging the gap between genotype and neuropathology. Neurobiol. Dis. 2007, 27:1-10.
11. Cohen J., Cohen P. Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences 1983, Erlbaum, Hillsdale, NJ.
12. Colom-Cadena M., Gelpi E., Martí M.J., Charif S., Dols-Icardo O., Blesa R., Clarimón J., Lleó A. MAPT H1 haplotype is associated with enhanced α-synuclein deposition in dementia with Lewy bodies. Neurobiol. Aging 2013, 34:936-942.
13. Dean D.C., Jerskey B.A., Chen K., Protas H., Thiyyagura P., Roontiva A., O'Muircheartaigh J., Dirks H., Waskiewicz N., Lehman K., Siniard A.L., Turk M.N., Hua X., Madsen S.K., Thompson P.M., Fleisher A.S., Huentelman M.J., Deoni S.C.L., Reiman E.M. Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study. JAMA Neurol 2014, 71:11-22.
14. Dove A., Brett M., Cusack R., Owen A.M. Dissociable contributions of the mid-ventrolateral frontal cortex and the medial temporal lobe system to human memory. Neuroimage 2006, 31:1790-1801.
15. Evans J.R., Mason S.L., Williams-Gray C.H., Foltynie T., Brayne C., Robbins T.W., Barker R.A. The natural history of treated Parkinson's disease in an incident, community based cohort. J.Neurol. Neurosurg. Psychiatry 2011, 82:1112-1118.
16. Fernández G., Weyerts H., Schrader-Bölsche M., Tendolkar I., Smid H.G., Tempelmann C., Hinrichs H., Scheich H., Elger C.E., Mangun G.R., Heinze H.J. Successful verbal encoding into episodic memory engages the posterior hippocampus: a parametrically analyzed functional magnetic resonance imaging study. J.Neurosci. 1998, 18:1841-1847.
17. Folstein M.F., Folstein S.E., McHugh P.R. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J.Psychiatr. Res. 1975, 12:189-198.
18. Foltynie T., Brayne C.E.G., Robbins T.W., Barker R.A. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain J. Neurol. 2004, 127:550-560.
19. Gibb W.R., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J.Neurol. Neurosurg. Psychiatry 1988, 51:745-752.
20. Goetz C.G., Tilley B.C., Shaftman S.R., Stebbins G.T., Fahn S., Martinez-Martin P., Poewe W., Sampaio C., Stern M.B., Dodel R., Dubois B., Holloway R., Jankovic J., Kulisevsky J., Lang A.E., Lees A., Leurgans S., LeWitt P.A., Nyenhuis D., Olanow C.W., Rascol O., Schrag A., Teresi J.A., van Hilten J.J., LaPelle N. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. Off. J. Mov. Disord. Soc 2008, 23:2129-2170.
21. Goris A., Williams-Gray C.H., Clark G.R., Foltynie T., Lewis S.J.G., Brown J., Ban M., Spillantini M.G., Compston A., Burn D.J., Chinnery P.F., Barker R.A., Sawcer S.J. Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease. Ann. Neurol. 2007, 62:145-153.
22. Helkala E.L., Laulumaa V., Soininen H., Riekkinen P.J. Recall and recognition memory in patients with Alzheimer's and Parkinson's diseases. Ann. Neurol. 1988, 24:214-217.
23. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
24. Kim H. Neural activity that predicts subsequent memory and forgetting: a meta-analysis of 74 fMRI studies. Neuroimage 2011, 54:2446-2461.
25. Kwok J.B.J., Teber E.T., Loy C., Hallupp M., Nicholson G., Mellick G.D., Buchanan D.D., Silburn P.A., Schofield P.R. Tau haplotypes regulate transcription and are associated with Parkinson's disease. Ann. Neurol. 2004, 55:329-334.
26. Machulda M.M., Ward H.A., Borowski B., Gunter J.L., Cha R.H., O'Brien P.C., Petersen R.C., Boeve B.F., Knopman D., Tang-Wai D.F., Ivnik R.J., Smith G.E., Tangalos E.G., Jack C.R. Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology 2003, 61:500-506.
27. Milner B., Squire L.R., Kandel E.R. Cognitive neuroscience and the study of memory. Neuron 1998, 20:445-468.
28. Mioshi E., Dawson K., Mitchell J., Arnold R., Hodges J.R. The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int. J. Geriatr. Psychiatry 2006, 21:1078-1085.
29. Morley J.F., Xie S.X., Hurtig H.I., Stern M.B., Colcher A., Horn S., Dahodwala N., Duda J.E., Weintraub D., Chen-Plotkin A.S., Van Deerlin V., Falcone D., Siderowf A. Genetic influences on cognitive decline in Parkinson's disease. Mov. Disord. 2012, 27:512-518.
30. Myers A.J., Pittman A.M., Zhao A.S., Rohrer K., Kaleem M., Marlowe L., Lees A., Leung D., McKeith I.G., Perry R.H., Morris C.M., Trojanowski J.Q., Clark C., Karlawish J., Arnold S., Forman M.S., Van Deerlin V., de Silva R., Hardy J. The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol. Dis 2007, 25:561-570.
31. Nelson H. National Adult Reading Test: Test Manual 1982, NFER-Nelson, Windsor, Berks.
32. Pillon B., Deweer B., Agid Y., Dubois B. Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases. Arch. Neurol. 1993, 50:374-379.
33. Preacher K.J. Calculation for the Test of the Difference between Two Independent Correlation Coefficients [Computer Software] 2002, Available at: http://www.quantpsy.org. Accessed October 30, 2014.
34. Rademakers R., Melquist S., Cruts M., Theuns J., Del-Favero J., Poorkaj P., Baker M., Sleegers K., Crook R., De Pooter T., Bel Kacem S., Adamson J., Van den Bossche D., Van den Broeck M., Gass J., Corsmit E., De Rijk P., Thomas N., Engelborghs S., Heckman M., Litvan I., Crook J., De Deyn P.P., Dickson D., Schellenberg G.D., Van Broeckhoven C., Hutton M.L. High-density SNP haplotyping suggests altered regulation of tau geneexpression in progressive supranuclear palsy. Hum. Mol. Genet 2005, 14:3281-3292.
35. Ranganath C., D'Esposito M. Medial temporal lobe activity associated with active maintenance of novel information. Neuron 2001, 31:865-873.
36. Samaranch L., Cervantes S., Barabash A., Alonso A., Cabranes J.A., Lamet I., Ancín I., Lorenzo E., Martínez-Lage P., Marcos A., Clarimón J., Alcolea D., Lleó A., Blesa R., Gómez-Isla T., Pastor P. The Effect of MAPT H1 and APOE ε4 on Transition from Mild Cognitive Impairment to Dementia. J. Alzheimers Dis 2010, 22:1065-1071.
37. Setó-Salvia N., Clarimón J., Pagonabarraga J., Pascual-Sedano B., Campolongo A., Combarros O., Mateo J.I., Regaña D., Martínez-Corral M., Marquié M., Alcolea D., Suárez-Calvet M., Molina-Porcel L., Dols O., Gómez-Isla T., Blesa R., Lleó A., Kulisevsky J. Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes. Arch. Neurol 2011, 68:359-364.
38. Simón-Sánchez J., Schulte C., Bras J.M., Sharma M., Gibbs J.R., Berg D., Paisan-Ruiz C., Lichtner P., Scholz S.W., Hernandez D.G., Krüger R., Federoff M., Klein C., Goate A., Perlmutter J., Bonin M., Nalls M.A., Illig T., Gieger C., Houlden H., Steffens M., Okun M.S., Racette B.A., Cookson M.R., Foote K.D., Fernandez H.H., Traynor B.J., Schreiber S., Arepalli S., Zonozi R., Gwinn K., van der Brug M., Lopez G., Chanock S.J., Schatzkin A., Park Y., Hollenbeck A., Gao J., Huang X., Wood N.W., Lorenz D., Deuschl G., Chen H., Riess O., Hardy J.A., Singleton A.B., Gasser T. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet 2009, 41:1308-1312.
39. Sperling R., Bates J., Chua E., Cocchiarella A., Rentz D., Rosen B., Schacter D.L., Albert M.S. fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J.Neurol. Neurosurg. Psychiatry 2003, 74:44-50.
40. Suckling J., Bullmore E. Permutation tests for factorially designed neuroimaging experiments. Hum. Brain Mapp. 2004, 22:193-205.
41. Tobin J.E., Latourelle J.C., Lew M.F., Klein C., Suchowersky O., Shill H.A., Golbe L.I., Mark M.H., Growdon J.H., Wooten G.F., Racette B.A., Perlmutter J.S., Watts R., Guttman M., Baker K.B., Goldwurm S., Pezzoli G., Singer C., Saint-Hilaire M.H., Hendricks A.E., Williamson S., Nagle M.W., Wilk J.B., Massood T., Laramie J.M., DeStefano A.L., Litvan I., Nicholson G., Corbett A., Isaacson S., Burn D.J., Chinnery P.F., Pramstaller P.P., Sherman S., Al-hinti J., Drasby E., Nance M., Moller A.T., Ostergaard K., Roxburgh R., Snow B., Slevin J.T., Cambi F., Gusella J.F., Myers R.H. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology 2008, 71:28-34.
42. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002, 15:273-289.
43. Weintraub D., Dietz N., Duda J.E., Wolk D.A., Doshi J., Xie S.X., Davatzikos C., Clark C.M., Siderowf A. Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease. Brain 2012, 135:170-180.
44. Wider C., Ross O.A., Nishioka K., Heckman M.G., Vilariño-Güell C., Jasinska-Myga B., Erketin-Taner N., Rademakers R., Graff-Radford N.R., Mash D.C., Papapetropoulos S., Duara R., Uchikado H., Wszolek Z.K., Farrer M.J., Dickson D.W. An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology. J. Neurol. Neurosurg. Psychiatry 2012, 83:424-429.
45. Williams-Gray C.H., Evans J.R., Goris A., Foltynie T., Ban M., Robbins T.W., Kolachana B.S., Weinberger D.R., Sawcer S.J., Barker R.A., Brayne C. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain J. Neurol. 2009, 132:2958-2969.
46. Williams-Gray C.H., Hampshire A., Robbins T.W., Owen A.M., Barker R.A. Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease. J.Neurosci. 2007, 27:4832-4838.
47. Williams-Gray C.H., Mason S.L., Evans J.R., Foltynie T., Brayne C., Robbins T.W., Barker R.A. The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort. J.Neurol. Neurosurg. Psychiatry 2013, 84:1258-1264.
48. Yarnall A.J., Breen D.P., Duncan G.W., Khoo T.K., Coleman S.Y., Firbank M.J., Nombela C., Winder-Rhodes S., Evans J.R., Rowe J.B., Mollenhauer B., Kruse N., Hudson G., Chinnery P.F., O'Brien J.T., Robbins T.W., Wesnes K., Brooks D.J., Barker R.A., Burn D.J., ICICLE-PD Study Group Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. Neurology 2014, 82:308-316.